Polyphenols targeting MAPK mediated oxidative stress and inflammation in rheumatoid arthritis
Freeman, J.S
The most common concern relates to gastrointestinal side effects , as both medication classes can cause nausea, vomiting, diarrhoea, and abdominal discomfort
PubChem Reference: View compound profile on NIH PubChem Key Characteristics MOLECULAR PROFILE Formula: C 62 H 98 N 16 O 22 Weight: 1,419.53 g/mol CAS: 137525-51-0 Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val PHYSICAL PROPERTIES Form: White to off-white lyophilized powder Solubility: Readily dissolves in water Stability: Stable across various pH conditions Storage: Keep refrigerated 3646 F (28 C) Related products DSIP $55.00 $90.00Price range: $55.00 through $90.00 CJC-1295 $60.00 $95.00Price range: $60.00 through $95.00
Signs of reduced efficiency
Phase III results for retatrutide are set to be released later in 2025 and in early 2026, but an earlier phase II trial recorded between a 7.2% and 17.5% reduction in body weight after 24 weeks, depending on the dose (7.2% on 1mg, 17.5% on 12mg), and up to a 24.2% reduction in body weight after 48 weeks for those on 12mg (-8.7% change for those on 1mg) 8
